29 related articles for article (PubMed ID: 23174568)
1. Recognition of oxidized albumin and thyroid antigens by psoriasis autoantibodies. A possible role of reactive-oxygen-species induced epitopes in chronic plaque psoriasis.
Al-Shobaili HA; Ahmed AA; Rasheed Z
Saudi Med J; 2015 Dec; 36(12):1408-19. PubMed ID: 26620982
[TBL] [Abstract][Full Text] [Related]
2. Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332.
Kikuchi K; Natsuga K; Shinkuma S; Nishie W; Kajita S; Sato H; Shimizu H
J Am Acad Dermatol; 2011 Oct; 65(4):878-880. PubMed ID: 21920249
[No Abstract] [Full Text] [Related]
3. Bullous pemphigoid with IgG autoantibodies to the α3 subunit of laminin 332 associated with psoriasis vulgaris.
Ohashi M; Takagi H; Mizutani Y; Seishima M; Koga H; Hashimoto T
Eur J Dermatol; 2017 Jun; 27(3):306-307. PubMed ID: 28468743
[No Abstract] [Full Text] [Related]
4. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
[No Abstract] [Full Text] [Related]
5. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.
Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T
J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805
[No Abstract] [Full Text] [Related]
6. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
7. Pemphigoid with autoantibodies to all laminin 332 subunits and BP230 developing vesicles within psoriatic plaques.
Ohata C; Mori Y; Tokita T; Koga H; Ohyama B; Sogame R; Hamada T; Ishii N; Furumura M; Hashimoto T
Eur J Dermatol; 2012; 22(6):812-3. PubMed ID: 23174568
[No Abstract] [Full Text] [Related]
8. Concomitant bullous pemphigoid and dermatitis herpetiformis.
Schulze F; van Beek N; Terheyden P; Zillikens D; Schmidt E
Dermatology; 2013; 226(3):217-21. PubMed ID: 23775006
[TBL] [Abstract][Full Text] [Related]
9. Bullous pemphigoid: from the clinic to the bench.
Di Zenzo G; Della Torre R; Zambruno G; Borradori L
Clin Dermatol; 2012; 30(1):3-16. PubMed ID: 22137222
[TBL] [Abstract][Full Text] [Related]
10. [Bullous pemphigoid].
Ohyama M; Amagai M
Ryoikibetsu Shokogun Shirizu; 2000; (31):274-6. PubMed ID: 11269078
[No Abstract] [Full Text] [Related]
11. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
Schmidt T; Sitaru C; Amber K; Hertl M
Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
[TBL] [Abstract][Full Text] [Related]
12. Role of MHC Class II genes in the pathogenesis of pemphigoid.
Zakka LR; Reche P; Ahmed AR
Autoimmun Rev; 2011 Nov; 11(1):40-7. PubMed ID: 21782980
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
